09Aug, 2022 CereVasc Announces FDA Approval of Second IDE Study of the eShunt® SystemAdmin2023-11-06T21:48:30+00:00August 9th, 2022|Press Release|Read More
25Apr, 2022 First patient treated in CereVasc® clinical trial of eShunt® System for Normal Pressure HydrocephalusAdmin2023-11-06T21:37:10+00:00April 25th, 2022|Press Release|Read More
08Feb, 2022 CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt® System for Patients with Normal Pressure HydrocephalusAdmin2023-11-06T21:21:09+00:00February 8th, 2022|Press Release|Read More
07Dec, 2021 CereVasc Announces Publication of First-in-Human Case Report of its eShunt System for the Treatment of Communicating HydrocephalusAdmin2023-11-06T21:13:31+00:00December 7th, 2021|Press Release|Read More
10Feb, 2021 First patient treated in CereVasc clinical trial of eShunt™ System for communicating hydrocephaluscerevasc2023-02-14T15:48:38+00:00February 10th, 2021|Press Release|Read More
04Nov, 2019 CereVasc, LLC Receives Approval to Initiate First-in-Human Clinical Study of the eShunt Systemcerevasc2023-02-14T15:48:39+00:00November 4th, 2019|Press Release|Read More
